TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Osteopore Ltd. ( (AU:OSX) ) just unveiled an update.
Osteopore Limited has launched OsteoRx, a special purpose vehicle aimed at advancing cellular regenerative medicine, with an initial investment of AUD 0.5 million. This strategic move involves a partnership with renowned scientists and a controlling stake in RxCell Inc, enhancing Osteopore’s leadership in the regenerative medicine sector and expanding its influence in the growing stem cell market.
More about Osteopore Ltd.
Osteopore Limited is an Australian-Singaporean company specializing in regenerative medicine. It is recognized globally for its 3D-printed biomimetic and bioresorbable implants, focusing on innovations in tissue regeneration and longevity science.
Average Trading Volume: 3,098,075
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$2.85M
For an in-depth examination of OSX stock, go to TipRanks’ Overview page.